跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,452 条关于
“PI3K/mTOR pathways”
全部
9,452
临床试验
4,974
药物
176
机构
19
资讯
4,283
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
10个月前
£1.5M CONNECT TarGeT Trial Launches Precision Medicine Approach for Childhood Brain Cancer
9个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
2年前
Celcuity's Gedatolisib Projected to Reach $155M Annual Revenue by 2034 for Breast Cancer Treatment
11个月前
Frontier Medicines Unveils FMC-242, Novel PI3Kα/RAS Inhibitor Targeting Cancer's Most Common Genetic Drivers
去年
Kazia Therapeutics to Meet with FDA on Paxalisib's Glioblastoma Registration Pathway
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
去年
Gedatolisib Shows Promising 77-Month Overall Survival in Advanced Breast Cancer Phase 1b Trial
3个月前
Kazia Therapeutics Triples Enrollment in Phase 1b Trial of Paxalisib for Advanced Triple Negative Breast Cancer
去年
Kazia Therapeutics Highlights Clinical Data and Pipeline Progress at November 2024 Corporate Presentation
第 1 页,共 429 页
上一页
下一页